Robert Timmerman

Robert Timmerman

University of Texas Southwestern Medical Center

H-index: 76

North America-United States

About Robert Timmerman

Robert Timmerman, With an exceptional h-index of 76 and a recent h-index of 52 (since 2020), a distinguished researcher at University of Texas Southwestern Medical Center, specializes in the field of brain tumors, lung cancer, kidney cancer, metastases.

His recent articles reflect a diverse array of research interests and contributions to the field:

Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy

Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.

Rethinking the potential role of dose painting in personalized ultra-fractionated stereotactic adaptive radiotherapy

Abstract PO4-09-12: Academic-community partnership bridges disparities in African American patient representation in accelerated partial breast irradiation clinical trials

Understanding the PULSAR Effect in Combined Radiotherapy and Immunotherapy through Attention Mechanisms with a Transformer Model

Abstract PO2-22-06: MRI response Assessment of Single Fraction Pre-operative Stereotactic Radiotherapy: Preliminary results

Optimizing Risk Vs. Reward in the Era of Ablative Radiotherapy Through Calculated Useful Trauma (CUT)

Robert Timmerman Information

University

Position

Professor of Radiation Oncology

Citations(all)

31608

Citations(since 2020)

13640

Cited By

23407

hIndex(all)

76

hIndex(since 2020)

52

i10Index(all)

243

i10Index(since 2020)

180

Email

University Profile Page

University of Texas Southwestern Medical Center

Google Scholar

View Google Scholar Profile

Robert Timmerman Skills & Research Interests

brain tumors

lung cancer

kidney cancer

metastases

Top articles of Robert Timmerman

Title

Journal

Author(s)

Publication Date

Phase III randomized trial of stereotactic ablative radiotherapy (SAbR) for oligometastatic advanced renal carcinoma (EA8211-SOAR).

Raquibul Hannan

Se Eun Kim

Suzanne Cole

Elizabeth Marie Wulff-Burchfield

Andrew Wentland

...

2024/2/1

BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy

International Journal of Radiation Oncology* Biology* Physics

Lucas K Vitzthum

Murat Surucu

Michael F Gensheimer

Nataliya Kovalchuk

Bin Han

...

2024/4/1

Circulating tumor DNA in the surveillance of patients with oligometastatic renal cell carcinoma treated with stereotactic ablative radiation.

Young Suk Suk Kwon

Laurentiu Pop

Maggie Janell Stein

Alana Christie

Subrata Manna

...

2024/2/1

Rethinking the potential role of dose painting in personalized ultra-fractionated stereotactic adaptive radiotherapy

Frontiers in Oncology

Hao Peng

Jie Deng

Steve Jiang

Robert Timmerman

2024/3/20

Abstract PO4-09-12: Academic-community partnership bridges disparities in African American patient representation in accelerated partial breast irradiation clinical trials

Cancer Research

Ev Kakadiaris

Brian Lue

Young Suk Kwon

Prasanna Alluri

D Nathan Kim

...

2024/5/2

Understanding the PULSAR Effect in Combined Radiotherapy and Immunotherapy through Attention Mechanisms with a Transformer Model

arXiv preprint arXiv:2403.04175

Hao Peng

Casey Moore

Debabrata Saha

Steve Jiang

Robert Timmerman

2024/3/7

Abstract PO2-22-06: MRI response Assessment of Single Fraction Pre-operative Stereotactic Radiotherapy: Preliminary results

Cancer Research

Baṣak Dogan

Sunati Sahoo

Marilyn Leitch

Prasanna Alluri

Robert Timmerman

...

2024/5/2

Optimizing Risk Vs. Reward in the Era of Ablative Radiotherapy Through Calculated Useful Trauma (CUT)

International Journal of Radiation Oncology, Biology, Physics

Nina N Sanford

Robert D Timmerman

2024/2/23

Abstract PS01-09: Early Results of a Phase I Pre-Operative Single Fraction Ablative Trial for Early Stage Breast Cancer

Cancer Research

Asal Rahimi

A Marilyn Leitch

Baṣak Dogan

Prasanna Alluri

Deborah Farr

...

2024/5/2

PULSAR Effect: Revealing Potential Synergies in Combined Radiation Therapy and Immunotherapy via Differential Equations

arXiv preprint arXiv:2402.06101

Samiha Rouf

Casey Moore

Debabrata Saha

Dan Nguyen

MaryLena Bleile

...

2024/2/8

An AI-based approach for modeling the synergy between radiotherapy and immunotherapy

Scientific Reports

Hao Peng

Casey Moore

Yuanyuan Zhang

Debabrata Saha

Steve Jiang

...

2024/4/8

Financial Toxicity and Patient Experience Outcomes on a Multi-Institutional Phase I Single Fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast Cancer

International Journal of Radiation Oncology, Biology, Physics

A Simmons

DJ Sher

N Kim

M Leitch

JA Haas

...

2023/10/1

Stereotactic Ablative Radiotherapy for the Treatment of Glandular Metastases from Renal Cell Carcinoma

International Journal of Radiation Oncology, Biology, Physics

T Song

M Miljanic

A Yen

J Kwon

A Christie

...

2023/10/1

Ultra-Hypofractionated Involved Site Radiation Therapy (ISRT) As Salvage or Bridging Therapy in Aggressive Non-Hodgkin Lymphomas

Blood

Tanooha Veeramachaneni

Xingzhe Li

Neil Desai

Heather R Wolfe

Elif Yilmaz

...

2023/11/28

The art of radiation therapy: The necessary risk of radiation necrosis for durable control of brain metastases

International Journal of Radiation Oncology, Biology, Physics

Michael T Milano

Scott G Soltys

Lawrence B Marks

Dwight E Heron

Ellen Yorke

...

2023/2/1

Eligibility of patients with esophageal and gastroesophageal cancer for biology-guided radiotherapy in a retrospective cohort.

Santiago Olaechea

Tidie Song

Linda Gilmore

Rodney E Infante

Neil B Desai

...

2023/6/1

Novel unconventional radiotherapy techniques: Current status and future perspectives–Report from the 2nd international radiation oncology online seminar

S Tubin

MC Vozenin

Y Prezado

M Durante

KM Prise

...

2023/5/1

Tumor treating fields combined with the PULSAR paradigm for radiotherapy and an immune checkpoint inhibitor enhances antitumor efficacy in vivo

Cancer Research

Narasimha K Karanam

Zengfu Shang

Robert Timmerman

Michael D Story

Debabrata Saha

2023/4/4

Workflow Considerations for Biology-Guided Radiotherapy (BgRT) Implementation

International Journal of Radiation Oncology, Biology, Physics

M Surucu

L Vitzthum

DT Chang

MF Gensheimer

N Kovalchuk

...

2023/10/1

Preliminary evaluation of PTV margins for online adaptive radiation therapy of the prostatic fossa

Practical Radiation Oncology

Howard E Morgan

Kai Wang

Yulong Yan

Neil Desai

Raquibul Hannan

...

2023/7/1

See List of Professors in Robert Timmerman University(University of Texas Southwestern Medical Center)

Co-Authors

H-index: 118
Walter Curran

Walter Curran

Emory & Henry College

H-index: 93
Jeff Michalski

Jeff Michalski

Washington University in St. Louis

H-index: 89
Steve Jiang

Steve Jiang

University of Texas Southwestern Medical Center

H-index: 87
Jeffrey Bradley

Jeffrey Bradley

Emory University

academic-engine